
Google’s US$2.1 billion Fitbit deal is sparking privacy concerns that the search giant will mine the health data of the 27 million people who use the fitness tracking device, The Financial Times (FT) reported on Thursday, November 21.
Privacy advocates and politicians have asked regulators to block the deal, fearing Google will tap Fitbit’s data to launch a healthcare service.
Senator Mark Warner (Democrat – Virginia) said earlier this month there are “serious concerns” the deal could give big tech an advantage in the growing personalized healthcare industry.
Rep. David Cicilline (Democrat – Rhode Island), chair of the House Antitrust Committee, has said the deal “would threaten to give [Google] yet another way to surveil users and entrench its monopoly power online.”
The Open Markets Institute, Public Citizen, and the Electronic Privacy Information Center are among the organizations that feel Google should not get control of Fitbit’s health data and “entrench its monopoly power.” They stated that Google should not be handed “yet another way to track our every move.”
Rick Osterloh, Google’s senior vice-president for devices and services, wrote in the blog post that Google would be “transparent about the data we collect and why.”
“We will never sell personal information to anyone. Fitbit health and wellness data will not be used for Google ads. And we will give Fitbit users the choice to review, move, or delete their data,” he wrote in the post when the deal was announced.
University of Tennessee law professor Maurice Stucke told FT that regulators have to come to a decision whether Google’s access to Fitbit data could give them an unfair competitive edge.
“When you have a company like Google, which has violated privacy laws multiple times . . . you can imagine it will raise significant concerns,” he said. The deal is leading some Fitbit users to ditch the device over fears that their data won’t be safe.
“Google could know which medications I take, and what medical diagnoses I have,” former Fitbit user Mike Carpenter said. “It makes me feel sick to my stomach.”
Full Content: PYMNTS
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas